TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ANGLE plc ( (GB:CLBX) ) has issued an update.
CelLBxHealth plc has announced a proposed fundraising of £6.8 million through a placing, subscription, and retail offer to support its revised business strategy. The company aims to transition from a research-focused organization to a commercially-driven model, leveraging strategic partnerships with multinational diagnostic companies to expand the adoption of its Parsortix® platform. The fundraising will facilitate the pursuit of commercial milestones, restructuring efforts, and the development of new CTC-based assays, positioning the company for future profitability and integration of CTCs into routine clinical practice.
The most recent analyst rating on (GB:CLBX) stock is a Hold with a £1.50 price target. To see the full list of analyst forecasts on ANGLE plc stock, see the GB:CLBX Stock Forecast page.
Spark’s Take on GB:CLBX Stock
According to Spark, TipRanks’ AI Analyst, GB:CLBX is a Neutral.
ANGLE plc’s overall stock score is primarily impacted by its poor financial performance and valuation, indicating significant challenges. Technical analysis also suggests bearish momentum. While the earnings call highlighted some positive developments, the need for additional funding and adverse market conditions weigh heavily on the stock’s outlook.
To see Spark’s full report on GB:CLBX stock, click here.
More about ANGLE plc
CelLBxHealth plc, formerly known as ANGLE plc, operates in the biotechnology industry, focusing on precision medicine through the development and commercialization of circulating tumor cell (CTC) platforms and tests for cancer. The company provides CTC tests as a service to biopharma and pharma companies for oncology clinical trials, aiming to transition into a commercially-driven model with product sales, laboratory services, and laboratory-developed tests.
Average Trading Volume: 2,845,992
Technical Sentiment Signal: Sell
Current Market Cap: £5.48M
See more data about CLBX stock on TipRanks’ Stock Analysis page.